Takeda Pharmaceutical Co Ltd (NYSE:TAK)

17.99
Delayed Data
As of Jul 15
 +0.20 / +1.12%
Today’s Change
15.50
Today|||52-Week Range
21.95
+6.96%
Year-to-Date

Today’s Trading

Previous close17.79
Today’s open17.80
Day’s range17.77 - 18.09
Volume1,754,972
Average volume (3 months)2,028,043
Market cap$55.7B
Data as of 4:02pm ET, 07/15/2019

Growth & Valuation

Earnings growth (last year)-52.61%
Earnings growth (this year)-247.38%
Earnings growth (next 5 years)+16.80%
Revenue growth (last year)+18.39%
P/E ratio34.4
Price/Sales2.08
Price/Book1.19

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+0.23+0.14%
ZTSZoetis Inc+0.26+0.23%
CELGCelgene-0.17-0.18%
VRTXVertex Pharmaceutica...+0.58+0.33%
Data as of 4:15pm ET, 07/15/2019

Financials

Last reporting dateMay 14, 2019
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$18.9B
Annual profit (last year)$984.1M
Net profit margin5.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, CEO &
Representative Director
Christophe Weber
Chief Financial Officer
Costa Saroukos
Corporate headquarters
Osaka, Osaka

Forecasts